Organogenesis Holdings Inc. (NASDAQ: ORGO) is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets, primarily in the United States.
The company’s advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs), Dermagraft for treating DFUs, PuraPly AM to address biofilm across a range of wound types and Affinity and NuShield to address various wound sizes and types.
Its surgical and sports medicine products included ReNu for in-office joint and tendon applications. NuCel is for bony fusion in the spine and extremities, and NuShield and Affinity is for surgical applications in targeted soft tissue repairs. PuraPly AM is for the surgical treatment of open wounds.
Oppenheimer has an Overweight rating and just raised its target price to $13 from $9. The posted consensus target is $10.50. Shares have spiked over the past 90 days and were trading near $9.50.
Westport Fuel Systems
This off-the radar stock has been on a roll and still has solid upside potential. Westport Fuel Systems Inc. (NASDAQ: WPRT) engineers, manufactures and supplies alternative fuel systems and components for use in transportation applications worldwide.
The company offers alternative fuel systems and components, which include a range of alternative fuels, such as liquefied petroleum gas, compressed natural gas, liquefied natural gas, renewable natural gas and hydrogen. It also offers independent aftermarket, original equipment manufacturers (OEMs) and delayed OEMs, electronics, current and advanced research and development programs, supply chain and product planning activities.
Its Westport High Pressure Direct Injection 2.0 is a fully integrated system that powers compression ignition engines by natural gas, which reduces greenhouse gas emissions. In addition, the company develops, sells and markets spark-ignited natural gas or propane engines. Its CWI engines are for transit, school and shuttle buses, conventional trucks and tractors, refuse collection trucks and specialty vehicles, such as short-haul port drayage trucks and street sweepers. Its products and services are used for passenger cars; light-, medium- and heavy-duty trucks; and horsepower, cryogenics and hydrogen applications.
Oppenheimer’s Overweight rating comes with a $10 price target, which was just hiked from $3. The $5.70 consensus target is lower. The stock has increased nicely over the past month and was trading just below $7.
These are five stocks for aggressive investors that look to get share count leverage on companies that have sizable upside potential. While not suited for all investors, these are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.